13F-HR filed by Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 22 holding rows worth $179,888,036.
- Accession
- 0000950123-24-005227
- Filer
- CIK 1822947
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 22 entries on the cover page, a total value of $179,888,036 stated on the cover page (in dollars after the unit check, H1), rows summing to $179,888,036 with VALUE read as dollars as filed, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFan Yu 028-20833
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 160,950 | $15,267,717 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 336,486 | $14,401,601 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 320,378 | $14,064,594 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 309,369 | $13,318,335 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 736,738 | $11,854,114 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 255,928 | $11,524,438 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 159,486 | $9,731,836 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 1,001,452 | $9,413,649 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 547,036 | $9,239,438 | dollars as filed | |
| GERON CORP | 374163103 | COM | 2,760,497 | $9,109,640 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 289,943 | $8,512,726 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 365,044 | $7,786,389 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 250,000 | $6,782,500 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 216,968 | $6,509,040 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 559,035 | $6,328,276 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 1,003,741 | $6,243,269 | dollars as filed | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 270,559 | $5,844,074 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 420,000 | $3,771,600 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 801,437 | $3,590,438 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 394,773 | $3,568,748 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M406 | COM NEW | 1,059,582 | $2,023,802 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 725,951 | $1,001,812 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-24-005227 | this filing | 2024-05-15 | acceptance time not in the bulk data set |